4//SEC Filing
JOHNSON & JOHNSON 4
Accession 0001193125-25-282669
$JNJCIK 0001235912operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 3:07 PM ET
Size
7.3 KB
Accession
0001193125-25-282669
Insider Transaction Report
Form 4
CVRx, Inc.CVRX
JOHNSON & JOHNSON
10% Owner
Transactions
- Sale
Common Stock
2025-11-12$10.00/sh−1,000$10,000→ 4,049,898 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)
Transactions
- Sale
Common Stock
2025-11-12$10.00/sh−1,000$10,000→ 4,049,898 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. 29 shares were sold at $10.04 and 971 shares were sold at $10.00.
- [F2]The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.
Documents
Issuer
CVRx, Inc.
CIK 0001235912
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000200406
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 3:07 PM ET
- Size
- 7.3 KB